<SEC-DOCUMENT>0001354457-23-000651-index.html : 20230908 <SEC-HEADER>0001354457-23-000651.hdr.sgml : 20230908 <ACCEPTANCE-DATETIME>20230908101120 ACCESSION NUMBER: 0001354457-23-000651 CONFORMED SUBMISSION TYPE: 25-NSE CONFIRMING COPY: PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20230908 DATE AS OF CHANGE: 20230908 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Nabriva Therapeutics plc CENTRAL INDEX KEY: 0001641640 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 25-NSE SEC ACT: 1934 Act SEC FILE NUMBER: 001-37558 BUSINESS ADDRESS: STREET 1: 25-28 NORTH WALL QUAY CITY: DUBLIN STATE: L2 ZIP: D01 H104 BUSINESS PHONE: (610) 816-6640 MAIL ADDRESS: STREET 1: 414 COMMERCE DRIVE STREET 2: STE 120 CITY: FORT WASHINGTON STATE: PA ZIP: 19034 FORMER COMPANY: FORMER CONFORMED NAME: Nabriva Therapeutics AG DATE OF NAME CHANGE: 20150507 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Nasdaq Stock Market LLC CENTRAL INDEX KEY: 0001354457 IRS NUMBER: 521165937 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 25-NSE BUSINESS ADDRESS: STREET 1: One Liberty Plaza CITY: New York STATE: NY ZIP: 10006 BUSINESS PHONE: 301-978-4144 MAIL ADDRESS: STREET 1: Office of General Counsel STREET 2: 805 King Farm Blvd. CITY: ROCKVILLE STATE: MD ZIP: 20850 FORMER COMPANY: FORMER CONFORMED NAME: The Nasdaq Stock Market LLC DATE OF NAME CHANGE: 20060224 </SEC-HEADER> <DOCUMENT> <TYPE>25-NSE <SEQUENCE>1 <FILENAME>primary_doc.xml <TEXT> Document 1 - file: primary_doc.html
Document 1 - RAW XML: primary_doc.xml
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.25 <SEQUENCE>2 <FILENAME>nbrvdelistreason.txt <TEXT> Document 2 - file: nbrvdelistreason.txt
</DOCUMENT> </SEC-DOCUMENT>